Blog
USDTL Forensic Blog
- CBD...THC – What's the Difference?
- Andre Sukta Elected to Board of Directors at SOFT
- Limits of Interpreting A Drug Test
- The Detection of Fentanyl Using Advanced Newborn Drug Testing
- The National and Global Movement of Methamphetamine
- Overdose Surveillance Data: Aimed to Support Public Safety and Public Health
- Kratom and its Controversial Threat to Public Health
- The Prevalence of Benzodiazepines in Today’s Opioid Epidemic
- Winter Weather Delays
- Amy Alexander, SPE Award Recipient 2018
newborn drug testing Forensic Technology bath salts alcohol use Forensic Drug Testing ethyl glucuronide fentanyl zolpidem FAS answer key umbilical cord testing ISO/IEC 17025 opiates PEth biomarker, Phosphatidylethanol EtG alcohol biomarker child hair testing adult and child drug testing diazepam drug ingestion methadone spice hair testing barbiturates drug testing adult and child alcohol testing neontal drug exposure teens FASD sedatives Innovation cannabinoids newborn drugs in fingernail synthetic cannabinoids direct biomarker opioids USDTL K2 NAS heroin drug exposure United States Drug Testing Laboratories, Inc. synthetic drug tramadol
A Forensic Drug Testing Laboratory Accredited by The College of American Pathologists.
© 2014 United States Drug Testing Laboratories, Inc. All Rights Reserved
Chicago Website Design by: Chicago Digital
